tiprankstipranks
Trending News
More News >
Contineum Therapeutics, Inc. Class A (CTNM)
:CTNM
US Market
Advertisement

Contineum Therapeutics, Inc. Class A (CTNM) Similar Stocks

Compare
201 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$12.16
$319.40M
-26.44%
6 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$39.91
$377.72M
326.84%
5 Buy
0 Hold
0 Sell
Strong Buy
Capricor Therapeutics
$7.48
$342.88M
-56.36%
9 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$4.17
$349.81M
84.51%
2 Buy
0 Hold
0 Sell
Moderate Buy
Immuneering
$6.50
$380.13M
192.79%
5 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$7.41
$358.85M
7.08%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
12.16
-4.37
-26.44%
TVRD
Tvardi Therapeutics
39.91
30.78
337.13%
CAPR
Capricor Therapeutics
7.48
-9.66
-56.36%
DRTS
Alpha Tau Medical Ltd
4.17
1.92
85.33%
IMRX
Immuneering
6.50
4.28
192.79%
ENGN
enGene Holdings
7.41
0.55
8.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis